Skip to content
10-K

Annual Report

CAPRICOR THERAPEUTICS, INC. CAPR

0001558370-25-003707

← back to feed
Filed
Mar 26, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 24, 2025 45.68M sh
Stock Issued FY 2024 · Sep 30, 2024 9.23M sh
Shares Diluted FY 2024 · Dec 31, 2023 26.78M sh
Capex FY 2024 · Dec 31, 2023 $1.31M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$25.6M
Cash And Equivalents FY 2024 · Dec 31, 2023 $14.69M
Current Liabilities FY 2024 · Dec 31, 2023 $31.27M
Total Liabilities FY 2024 · Dec 31, 2023 $36.13M
Current Assets FY 2024 · Dec 31, 2023 $50.86M
Total Assets FY 2024 · Dec 31, 2023 $58.73M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.83
Eps Basic FY 2024 · Dec 31, 2023 −$0.83
Sga Expense FY 2024 · Dec 31, 2023 $12.81M
Rd Expense FY 2024 · Dec 31, 2023 $36.45M
Net Income FY 2024 · Dec 31, 2023 −$22.29M
Operating Income FY 2024 · Dec 31, 2023 −$24.08M
Revenue FY 2024 · Dec 31, 2023 $25.18M
Stockholders Equity FY 2024 · Dec 31, 2022 $11.79M